SCHEMBL4958276

SCHEMBL4958276

Cc1ccnc(N=Nc2ccccc2)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.50
MEN1 O00255 7/20 0.50
MAPT P10636 6/20 0.50
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
MAPK1 P28482 4/20 0.50
ALDH1A1 P00352 4/20 0.50
TDP1 Q9NUW8 4/20 0.50
HSD17B10 Q99714 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
HIF1A Q16665 2/20 0.50
LMNA P02545 2/20 0.50
PKM P14618 2/20 0.50
TP53 P04637 1/20 0.50
CYP2D6 P10635 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
NFKB1 P19838 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2266835 0.77 CYP3A4 (0.64) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL2266833 0.77 CYP3A4 (0.64) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL23839685 0.71 HSD17B10 (0.42) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL14107227 0.71 MEN1 (0.54) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL13554427 0.70 KMT2A (0.58) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL13430940 0.69 MEN1 (0.52) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL2565537 0.69 TRPA1 (0.50) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL4780554 0.69 KMT2A (0.53) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL3398576 0.68 KMT2A (0.45) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL20537354 0.68 MEN1 (0.50) KMT2AMEN1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1991212-A1 MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS Braincells, Inc. (US) 2008-11-19 EP disclosed
WO-2007104035-A1 MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS BRAINCELLS, INC. (US) 2007-09-13 WO disclosed